A compound or a pharmaceutically acceptable salt thereof, composition, methods for treating or preventing a dopamine-relieved inhibition of dopamine resorption inhibition, attention deficit disorder, depression, obesity, parkinson's disease, a dependence, and a tic disorder, and, method for obtaining a compound

摘要

"COMPOSITION OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, COMPOSITION, METHODS FOR TREATMENT OR PREVENTION OF A DISEASE RELIEFED BY INHIBITION OF DOPAMINE REHABILITATION, DISEASE OF ATHENS DUE DISEASE, ATHENS DUE DISORDER, OF DEPENDENCE, AND A TICKET DISTURBANCE, AND METHOD FOR A COMPOUND. " The present invention relates to (-) -1- (3,4-dichlorophenyl) -3-azabicyclo [3.1.0] hexane and pharmaceutically acceptable salts thereof, compositions comprising (-) - 1- (3,4-dichlorophenyl) dichlorophenyl) -3-azabicyclo [3.1.0] hexane or a pharmaceutically acceptable salt thereof, and methods for treating or preventing a disorder relieved by dopamine reuptake inhibition. In one embodiment, the disorder is attention deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or a dependence disorder. The (-) - 1- (3,4-dichlorophenyl) -3 azabicyclo [3.1.0] hexane or pharmaceutically acceptable salt thereof is preferably substantially free of its corresponding (+) enantiomer.